1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Orthobiologics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6

3 Orthobiologics Market, Australia 9
3.1 Orthobiologics Market, Australia, Revenue ($m), 2015-2025 9
3.1.1 Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2015-2025 12
3.1.2 Bone Growth Stimulators Market, Australia, Revenue ($m), by Segment, 2015-2025 14
3.1.3 Soft Tissue Biologics Market, Australia, Revenue ($m), by Segment, 2015-2025 16
3.1.4 Viscosupplementation Market, Australia, Revenue ($m), by Segment, 2015-2025 18
3.2 Orthobiologics Market, Australia, Volume (Units), 2015-2025 20
3.2.1 Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2015-2025 23
3.2.2 Bone Growth Stimulators Market, Australia, Volume (Units), by Segment, 2015-2025 26
3.2.3 Soft Tissue Biologics Market, Australia, Volume (Units), by Segment, 2015-2025 28
3.2.4 Viscosupplementation Market, Australia, Volume (Units), by Segment, 2015-2025 30
3.3 Orthobiologics Market, Australia, Average Price ($), 2015-2025 32
3.4 Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2017 34
3.5 Orthobiologics Market, Australia, Company Share by Revenue ($m), 2017 35

4 Overview of Key Companies in Australia, Orthobiologics Market 37
4.1 Sanofi 37
4.1.1 Company Overview 37
4.2 DePuy Synthes Inc 37
4.2.1 Company Overview 37
4.3 Stryker Corp 37
4.3.1 Company Overview 37
4.4 Medtronic Plc 37
4.4.1 Company Overview 37
4.5 Zimmer Biomet Holdings Inc 38
4.5.1 Company Overview 38
4.6 ConMed Corporation 38
4.6.1 Company Overview 38
4.7 RTI Surgical Inc 38
4.7.1 Company Overview 38
4.8 LifeNet Health Inc 39
4.8.1 Company Overview 39
4.9 DJO Global Inc 39
4.9.1 Company Overview 39
4.10 AlloSource 39
4.10.1 Company Overview 39
4.11 Ferring Pharmaceuticals A/S 39
4.11.1 Company Overview 39
4.12 Bioventus LLC 40
4.12.1 Company Overview 40

5 Orthobiologics Market Pipeline Products 41

6 Financial Deals Landscape 43
6.1 Equity Offerings 43
6.1.1 Orthocell Raises USD1.1 Million in Private Placement of Shares 43
6.1.2 Orthocell to Raise Funds through Rights Offering of Shares 44

7 Appendix 45
7.1 Research Methodology 46
7.1.1 Coverage 46
7.1.2 Secondary Research 46
7.1.3 Primary Research 47
7.1.4 Market Modeling and Forecasting 48
7.1.5 Company Share Analysis 49
7.1.6 Distribution Share Analysis 50
7.1.7 Benchmarking 50
7.2 GlobalData Consulting 50
7.3 Contact Us 51
7.4 Disclaimer 51

1.1 List of Tables
Table 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2015-2020 10
Table 2: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2021-2025 11
Table 3: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2015-2020 13
Table 4: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2021-2025 13
Table 5: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2015-2020 15
Table 6: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2021-2025 15
Table 7: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2015-2020 17
Table 8: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2021-2025 17
Table 9: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2015-2020 19
Table 10: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2021-2025 19
Table 11: Orthobiologics Market, Australia, Volume (Units), 2015-2020 21
Table 12: Orthobiologics Market, Australia, Volume (Units), 2021-2025 22
Table 13: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2015-2020 24
Table 14: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2021-2025 25
Table 15: Bone Growth Stimulators Market, Australia, Volume (Units), 2015-2020 27
Table 16: Bone Growth Stimulators Market, Australia, Volume (Units), 2021-2025 27
Table 17: Soft Tissue Biologics Market, Australia, Volume (Units), 2015-2020 29
Table 18: Soft Tissue Biologics Market, Australia, Volume (Units), 2021-2025 29
Table 19: Viscosupplementation Market, Australia, Volume (Units), 2015-2020 31
Table 20: Viscosupplementation Market, Australia, Volume (Units), 2021-2025 31
Table 21: Orthobiologics Market, Australia, Average Price ($), 2015-2020 32
Table 22: Orthobiologics Market, Australia, Average Price ($), 2021-2025 33
Table 23: Orthobiologics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2017 34
Table 24: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2017 36
Table 25: Orthobiologics Market Pipeline Products 41
Table 26: Orthocell Raises USD1.1 Million in Private Placement of Shares 43
Table 27: Orthocell to Raise Funds through Rights Offering of Shares 44
Table 28: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 48

1.2 List of Figures
Figure 1: Orthobiologics Market, Australia, Revenue ($m), USD Constant, 2015-2025 9
Figure 2: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, 2015-2025 12
Figure 3: Bone Growth Stimulators Market, Australia, Revenue ($m), USD Constant, 2015-2025 14
Figure 4: Soft Tissue Biologics Market, Australia, Revenue ($m), USD Constant, 2015-2025 16
Figure 5: Viscosupplementation Market, Australia, Revenue ($m), USD Constant, 2015-2025 18
Figure 6: Orthobiologics Market, Australia, Volume (Units), 2015-2025 20
Figure 7: Bone Grafts and Substitutes Market, Australia, Volume (Units), 2015-2025 23
Figure 8: Bone Growth Stimulators Market, Australia, Volume (Units), 2015-2025 26
Figure 9: Soft Tissue Biologics Market, Australia, Volume (Units), 2015-2025 28
Figure 10: Viscosupplementation Market, Australia, Volume (Units), 2015-2025 30
Figure 11: Orthobiologics Market, Australia, Company Share (%) 2017 35

Companies Mentioned
- Sanofi
- DePuy Synthes Inc
- Stryker Corp
- Medtronic Plc
- Zimmer Biomet Holdings Inc
- ConMed Corporation
- RTI Surgical Inc
- LifeNet Health Inc
- DJO Global Inc
- AlloSource
- Ferring Pharmaceuticals A/S
- Bioventus LLC